A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
Cefepime, a newly developed cephalosporin, was administered to 27 patients with UTI, at a dose of 0.5 or 1.0 g i.v. twice a day. Of the 2 patients with acute uncomplicated pyelonephritis, one was evaluated as effectively treated according to the attending physicians. On application of the criteria of the Japanese UTI Committee, only one case was evaluable and was assessed moderately effectively treated. Of the 25 cases of complicated UTI, the efficacy rate according to the attending physiciansdoi:10.11250/chemotherapy1953.39.supplement2_469 fatcat:alvfpirrkfekxbvmzg3z7uphuu